Nlrp2tm1a(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Nlrp2tm1a(KOMP)Wtsi |
Name: |
NLR family, pyrin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4880891 |
Synonyms: |
Nlrp2tm1a |
Gene: |
Nlrp2 Location: Chr7:5301546-5354034 bp, - strand Genetic Position: Chr7, 3.07 cM, cytoband A1
|
Alliance: |
Nlrp2tm1a(KOMP)Wtsi page
|
IMPC: |
Nlrp2 gene page |
|
Mutant Cell Lines: |
3F1, EPD0703_2_A02, EPD0703_2_B01, EPD0864_1_E12 |
Germline Transmission: |
Earliest citation of germline transmission:
J:275254
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Conditional ready, Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 5330175 of Chromosome 7 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 5332477. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele can be created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. If cre expression occurs without flp expression, a reporter knockout mouse will be created. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
4 reference(s) |
|